Shotsy
For individuals using GLP-1 receptor agonists for weight management or Type 2 Diabetes who prioritize data-driven insights and privacy.
Shotsy GLP-1 TrackerSnapshot
Who is Shotsy?
Empowering GLP-1 medication users with data-driven tracking and clinical visualization tools to manage their weight-loss journey.
Target audience
Portfolio
Free 2Last updated
Shotsy GLP-1 Tracker
v3.2.5
3mo ago
Publisher DNA
What defines Shotsy?
Publisher DNA
Primary focus
Health & Fitness · GLP-1 medication tracking
Scale
indie
Target audience
Individuals using GLP-1 receptor agonists for weight management or Type 2 Diabetes who prioritize data-driven insights and privacy.
Signature Patterns
- •Niche focus on GLP-1 receptor agonist medication tracking
- •Subscription-based monetization with monthly and annual premium tiers
- •Privacy-centric architecture designed for sensitive health data
- •Rapid iteration cycle with frequent feature updates and refinements
Portfolio momentum
Released 12 updates for their single active title in the last 6 months, indicating an intense development and iteration cycle.
Portfolio
What does Shotsy ship?
Apps
2 apps analysed
Analysis in progress
Multi-medication scheduling addresses complex poly-pharmacy needs
- Estimated medication level charts provide actionable insights for managing injection schedules and symptoms
- Paywalling previously free features like medication level charts creates friction for long-term users
Distributed across 20 markets, strongest in Europe.
Based on 1 of 2 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (4)
- Brazil1 / 1
- Canada1 / 1
- Mexico1 / 1
- United States1 / 1
Europe (9)
- France1 / 1
- Germany1 / 1
- Italy1 / 1
- Netherlands1 / 1
- Portugal1 / 1
›+4 more europe markets
- Spain1 / 1
- Sweden1 / 1
- Turkey1 / 1
- United Kingdom1 / 1
Asia-Pacific (7)
- Australia1 / 1
- India1 / 1
- Indonesia1 / 1
- Japan1 / 1
- Singapore1 / 1
›+2 more asia-pacific markets
- South Korea1 / 1
- Vietnam1 / 1
Core markets (1/1 apps)
User Sentiment
How do users feel about their apps?
1
Positive apps
0
Neutral / mixed
0
Negative apps
75/100
Avg sentiment score
Rivals
Who does Shotsy compete with?
The rivals identified
Nemeses(1)
Massive user base and high release velocity make this the primary generalist threat for weight loss tracking.
Contenders(2)
Strong clinical focus and high update frequency position it as a reliable alternative for medical-grade tracking.
Dominates the behavioral psychology segment of weight loss, creating a high barrier to entry for simple trackers.
Same space(4)
Focuses on the physical activity component of weight loss, serving as a complementary tool for GLP-1 users.
Professional-grade supplement and medication management platform that serves the clinical side of the GLP-1 journey.
Provides advanced biometric analysis that complements the weight loss journey by tracking physiological stress.
Targets specific dietary niches that often intersect with GLP-1 medication users seeking metabolic health.
New entrants(1)
Aggressive release schedule and AI-first positioning indicate a rapid attempt to capture the automated logging market.
The Analyst's Read
The bottom line on Shotsy
Bottom line
Users report: Shotsy is a specialized indie developer successfully capturing the GLP-1 companion app niche through clinical data visualization. Their high user sentiment and intense update velocity signal strong product-market fit within a rapidly growing health sub-sector.
Frequently asked questions
How many apps does Shotsy publish?
What kind of apps does Shotsy make?
What is Shotsy's top app?
In how many countries are Shotsy's apps available?
What fed this analysis
- Apps analyzed:
- 1
- With full intel:
- 1
- With overview:
- 1
- Website scraped:
- yes
- Social presence:
- no